cell-free DNA
Mainz Biomed, Dante Labs Partner to Commercialize ColoAlert in Europe, UAE
Dante labs will market the test in Italy and the UAE, with Mainz initially processing samples in its lab and Dante later adopting IVD kits for in-house use.
Lucence Publishes Clinical Validation of LiquidHallmark Circulating Tumor DNA Test, Expands to RNA
Premium
The firm plans to ramp up US commercialization following the study, while continuing to develop its cell-free RNA diagnostic platform.
Mirvie Raises $60M in Series B Funding
The company plans to use the funding to propel the clinical and commercial development of its Mirvie RNA testing platform for pregnancy health.
Artemis DNA to Provide Datar Cancer Genetics Liquid Biopsy Tests in the US, Vietnam Under $250M Deal
Under the five-year exclusive agreement, Artemis DNA will offer Datar Cancer Genetics' Trucheck Pragma and Cancertrack tests in the US and Vietnam.
The South San Francisco-based startup recently published two studies showing the performance of its tests for predicting preterm birth and preeclampsia.
Apr 20, 2022
Mar 30, 2022
BillionToOne Raises $125M in Series C Funding Round
Aug 5, 2021
Jun 14, 2021
BillionToOne Raises $55M in Series B Financing
Apr 14, 2021
Mar 16, 2021